One institution is gatekeeper for product access in the country
|
None is gatekeeper for the whole market
|
Payer is the ultimate payer
|
Payers often intermediates
|
Payer in charge of all HC budget
|
Payers often limited to drugs
|
Payer keep patients till end of life
|
Patients turnover among Managed Care Organizations
|
Payers have limited influence on prescriptions
|
Payers have many tools to influence prescriptions
|
Patient records exist
|
Very limited patients IT records
|
Prices are controlled
|
Prices market based
|
Prices are transparent
|
Prices opaque
|
High level of cross border influence
|
Limited cross payers influence
|
| Health technology assessment well developed and used |
Limited use of HTA in formulary decisions |
